CN Stock MarketDetailed Quotes
300683 Wuhan Hiteck Biological Pharma
- 25.72
- +0.19+0.74%
Market Closed Dec 20 15:00 CST
3.37BMarket Cap-25.09P/E (TTM)
25.98High25.38Low13.30KlotVolume25.50Open25.53Pre Close34.21MTurnover1.09%Turnover RatioLossP/E (Static)130.89MShares36.1952wk High1.38P/B3.14BFloat Cap18.8052wk Low30.64Limit Up122.06MShs Float84.84Historical High20.42Limit Down2.35%Amplitude18.80Historical Low--Dividend TTM25.73Avg Price6.13KlotAsk--Div YieldTTM100Lot Size7.01KlotBid
Wuhan Hiteck Biological Pharma Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 2.87%450.99M | -0.64%284.62M | -4.87%131.89M | -12.54%602.28M | -19.80%438.43M | -26.03%286.45M | -16.59%138.64M | 12.03%688.63M | 39.32%546.64M | 71.69%387.23M |
| Operating revenue | 2.87%450.99M | -0.64%284.62M | -4.87%131.89M | -12.54%602.28M | -19.80%438.43M | -26.03%286.45M | -16.59%138.64M | 12.03%688.63M | 39.32%546.64M | 71.69%387.23M |
| Other operating revenue | ---- | -46.91%4.78M | ---- | -1.04%7.8M | ---- | 197.16%9M | ---- | 21.59%7.89M | ---- | -17.54%3.03M |
| Total operating cost | 5.37%533.19M | 3.46%341.12M | 20.19%185.59M | 3.34%714.28M | -4.78%506.04M | -8.91%329.72M | -4.45%154.42M | 14.83%691.22M | 42.52%531.42M | 66.08%361.96M |
| Operating cost | 0.92%246.97M | -6.28%154.34M | 1.67%79.25M | -2.77%345.06M | -14.42%244.73M | -19.26%164.68M | -6.43%77.95M | 34.02%354.88M | 110.45%285.96M | 190.40%203.97M |
| Operating tax surcharges | 28.80%5.04M | 23.65%3.38M | 23.93%1.42M | -2.96%5.47M | -3.49%3.91M | -0.65%2.73M | -4.12%1.15M | 58.69%5.64M | 43.63%4.05M | 17.04%2.75M |
| Operating expense | 0.84%100.16M | -5.13%64.06M | -11.48%27.79M | 1.55%128.66M | 2.63%99.32M | 14.04%67.53M | 1.64%31.4M | -13.02%126.71M | -6.06%96.78M | -9.27%59.21M |
| Administration expense | 30.18%95.13M | 28.27%62.11M | 114.77%49.44M | 20.80%113.33M | 7.49%73.08M | 8.18%48.42M | 15.88%23.02M | -3.58%93.81M | 0.95%67.99M | 1.94%44.76M |
| Financial expense | 45.43%-3.14M | 63.66%-1.73M | 92.64%-241.53K | 36.51%-7.14M | 34.95%-5.75M | 25.64%-4.77M | 3.32%-3.28M | 10.32%-11.25M | 3.29%-8.83M | 2.64%-6.41M |
| -Interest expense (Financial expense) | 19.42%2.05M | 29.68%1.41M | 222.14%1.19M | 114.35%2.39M | 47.68%1.72M | 11.54%1.09M | -28.95%369.05K | 124.92%1.12M | 259.82%1.16M | 506.81%976.19K |
| -Interest Income (Financial expense) | 27.97%-5.61M | 42.13%-3.53M | 57.45%-1.62M | 22.29%-9.99M | 24.79%-7.79M | 18.35%-6.11M | 5.69%-3.8M | 5.45%-12.86M | -5.76%-10.36M | -6.48%-7.48M |
| Research and development | -1.88%89.03M | 15.33%58.97M | 15.47%27.94M | 6.15%128.9M | 6.16%90.74M | -11.37%51.13M | -18.70%24.2M | 17.71%121.43M | 17.20%85.47M | 34.87%57.69M |
| Credit Impairment Loss | -84.99%324.45K | -65.49%722.16K | -40.39%564.6K | 74.31%-974.97K | 9,122.68%2.16M | 253.44%2.09M | 122.90%947.22K | -115.97%-3.79M | 100.17%23.43K | 88.08%-1.36M |
| Asset Impairment Loss | -198.90%-1.67M | -145.44%-1.41M | 370.69%17.7M | -81.03%-60.12M | 118.76%1.69M | 148.90%3.11M | --3.76M | -183.99%-33.21M | -17.79%-8.99M | -28.90%-6.36M |
| Other net revenue | 34.08%32.9M | 35.29%27.71M | 179.60%25.81M | -635.32%-31.08M | 276.72%24.53M | 1,327.85%20.48M | 651.66%9.23M | -149.24%-4.23M | 196.46%6.51M | 123.24%1.43M |
| Fair value change income | -60.34%4.62M | -10.43%6.1M | 149.25%5.81M | -85.02%1.9M | 241.85%11.65M | 1,143.19%6.81M | -10.20%2.33M | 3,903.39%12.67M | 335.88%3.41M | 38.08%-653.22K |
| Invest income | 152.12%7.53M | 90.13%4.08M | 10,050.76%239.11K | 42.06%15.69M | -44.36%2.99M | -63.66%2.15M | -98.48%2.36K | -23.00%11.04M | -47.12%5.37M | -29.83%5.91M |
| -Including: Investment income associates | ---- | ---- | ---- | -15.16%-2.77M | ---- | ---- | ---- | -9,453.53%-2.4M | ---- | ---- |
| Asset deal income | 97.93%-45.09K | -210.95%-43.5K | -210.95%-43.5K | -282.04%-358.67K | -828.31%-2.18M | 143.06%39.21K | --39.21K | 48.12%-93.88K | 684.93%299.27K | -85.71%-91.05K |
| Other revenue | 168.98%22.13M | 190.92%18.26M | -28.26%1.54M | 39.69%12.79M | 28.58%8.23M | 57.06%6.28M | -17.65%2.15M | 11.53%9.16M | 8.67%6.4M | 38.16%4M |
| Operating profit | -14.47%-49.31M | -26.34%-28.79M | -325.78%-27.89M | -1,997.07%-143.07M | -298.19%-43.07M | -185.32%-22.78M | -212.60%-6.55M | -131.97%-6.82M | 70.47%21.73M | 1,762.08%26.71M |
| Add:Non operating Income | 82.57%222.45K | -70.62%32.95K | -96.16%3.75K | -59.40%172.06K | -43.20%121.85K | -32.71%112.15K | -96.69%97.53K | -28.81%423.83K | -62.53%214.51K | -19.48%166.67K |
| Less:Non operating expense | -60.54%2.45M | -64.98%716.34K | 54.39%559.25K | 537.43%9.09M | 697.99%6.22M | 265.72%2.05M | 59.65%362.23K | -3.65%1.43M | -16.04%779.56K | -17.20%559.31K |
| Total profit | -4.81%-51.54M | -19.22%-29.47M | -317.39%-28.45M | -1,842.57%-151.99M | -332.29%-49.17M | -193.94%-24.72M | -179.82%-6.82M | -138.25%-7.82M | 70.81%21.17M | 2,624.82%26.31M |
| Less:Income tax cost | 52.24%-9.34M | 57.73%-5.03M | -114.80%-10.95M | -32,106.33%-23.74M | -453.74%-19.56M | -1,228.50%-11.9M | -228.44%-5.1M | 100.78%74.18K | 47.02%-3.53M | 121.39%1.05M |
| Net profit | -42.48%-42.2M | -90.68%-24.44M | -919.75%-17.49M | -1,523.72%-128.24M | -219.90%-29.62M | -150.74%-12.82M | -117.00%-1.72M | -126.31%-7.9M | 29.60%24.7M | 328.48%25.26M |
| Net profit from continuing operation | -42.48%-42.2M | -90.68%-24.44M | -919.75%-17.49M | -1,523.72%-128.24M | -219.90%-29.62M | -150.74%-12.82M | -117.00%-1.72M | -126.31%-7.9M | 29.60%24.7M | 328.48%25.26M |
| Less:Minority Profit | 22.73%-2.45M | 0.90%-1.67M | -288.92%-946.15K | -221.02%-7.42M | -154.04%-3.18M | -126.45%-1.69M | -110.14%-243.28K | 159.73%6.13M | 1,289.40%5.88M | 583.12%6.39M |
| Net profit of parent company owners | -50.32%-39.74M | -104.58%-22.77M | -1,024.00%-16.55M | -761.20%-120.82M | -240.47%-26.44M | -158.96%-11.13M | -119.14%-1.47M | -150.73%-14.03M | 1.00%18.82M | 161.49%18.87M |
| Earning per share | ||||||||||
| Basic earning per share | -42.86%-0.3 | -88.89%-0.17 | -550.00%-0.13 | -745.45%-0.93 | -240.00%-0.21 | -160.00%-0.09 | -133.33%-0.02 | -142.31%-0.11 | -16.67%0.15 | 114.29%0.15 |
| Diluted earning per share | -42.86%-0.3 | -88.89%-0.17 | -550.00%-0.13 | -745.45%-0.93 | -240.00%-0.21 | -160.00%-0.09 | -133.33%-0.02 | -142.31%-0.11 | -16.67%0.15 | 114.29%0.15 |
| Other composite income | ||||||||||
| Total composite income | -42.48%-42.2M | -90.68%-24.44M | -919.75%-17.49M | -1,523.72%-128.24M | -219.90%-29.62M | -150.74%-12.82M | -117.00%-1.72M | -126.31%-7.9M | 29.60%24.7M | 328.48%25.26M |
| Total composite income of parent company owners | -50.32%-39.74M | -104.58%-22.77M | -1,024.00%-16.55M | -761.20%-120.82M | -240.47%-26.44M | -158.96%-11.13M | -119.14%-1.47M | -150.73%-14.03M | 1.00%18.82M | 161.49%18.87M |
| Total composite income of minority owners | 22.73%-2.45M | 0.90%-1.67M | -288.92%-946.15K | -221.02%-7.42M | -154.04%-3.18M | -126.45%-1.69M | -110.14%-243.28K | 159.73%6.13M | 1,289.40%5.88M | 583.12%6.39M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
